| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010812 |
| Receipt No. | R000012080 |
| Official scientific title of the study | A study of interferon beta/ ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients. |
| Date of disclosure of the study information | 2013/05/27 |
| Last modified on | 2018/09/21 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A study of interferon beta/ ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients. | |
| Title of the study (Brief title) | Interferon beta with/without ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients. | |
| Region |
|
|
| Condition | ||
| Condition | Chronic hepatitis C patients and compensated cirrhosis patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To verify whether can be improved therapeutic effect by the combined use of non-activated vitamin D to IFN beta or IFN beta / RBV, for chronic hepatitis C and compensated cirrhosis patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Negative result of HCV RNA test at 24 weeks after therapy. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Chronic hepatitis C with high viral load:
Vitamin D(2000IU/day)for 4 weeks, vitamin D, IFN-beta(6 MIU)and ribavirin(600-1000mg/day)for 48 weeks. Negative result of HCV RNA test at 12-36 weeks for 72 weeks treatment. HCV serogroup 2 patients were treatment for 24 weeks. Chronic hepatitis C with low viral load :retreatment patients: Vitamin D(2000IU/day)for 4 weeks, vitamin D, IFN-beta(6 MIU) and ribavirin(600-1000mg/day)for 24 weeks. Chronic hepatitis C with low viral load:naive patients: Vitamin D(2000IU/day)for 4 weeks, vitamin D and IFN-beta(6 MIU) for 8-24 weeks. Compensated cirrhosis patients: Vitamin D(2000IU/day)for 4 weeks, vitamin D and IFN-beta(6 MIU) for 36 weeks. |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Chronic hepatitis C and compensated cirrhosis patients with serogroup 1 and low viral load, with serogroup 2. | |||
| Key exclusion criteria | pregnant women and nursing mothers | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Mochida |
| Organization | Saitama Medical University |
| Division name | Division of Gastroenterology and Hepatology ,internal Medicine |
| Address | 38,Morohongou,Moroyama-machi,Iruma-gun,Saitama,Japan |
| TEL | 049-276-1111 |
| hirb@saitama-med.ac.jp | |
| Public contact | |
| Name of contact person | Nobuaki Nakayama |
| Organization | Saitama Medical University |
| Division name | Division of Gastroenterology and Hepatology ,internal Medicine |
| Address | 38,Morohongou,Moroyama-machi,Iruma-gun,Saitama,Japan |
| TEL | 049-276-1111 |
| Homepage URL | |
| hirb@saitama-med.ac.jp | |
| Sponsor | |
| Institute | Saitama Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saitama Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012080 |